{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T16:10:05Z","timestamp":1745770205944,"version":"3.40.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T00:00:00Z","timestamp":1745712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T00:00:00Z","timestamp":1745712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004286","name":"Santen","doi-asserted-by":"publisher","award":["a collaborative research project"],"award-info":[{"award-number":["a collaborative research project"]}],"id":[{"id":"10.13039\/501100004286","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-99287-z","type":"journal-article","created":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T15:36:24Z","timestamp":1745768184000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Valosin-containing protein modulator KUS121 protects retinal neurons in a rat model of anterior ischemic optic neuropathy"],"prefix":"10.1038","volume":"15","author":[{"given":"Chinami","family":"Kikkawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanako Ohashi","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Hata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiko","family":"Iwai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akitaka","family":"Tsujikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,27]]},"reference":[{"key":"99287_CR1","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1007\/s00417-013-2399-z","volume":"251","author":"SS Hayreh","year":"2013","unstructured":"Hayreh, S. S. Ischemic optic neuropathies - where are we now? Graefes Arch. Clin. Exp. Ophthalmol. 251, 1873\u20131884. https:\/\/doi.org\/10.1007\/s00417-013-2399-z (2013).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"99287_CR2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.preteyeres.2008.11.002","volume":"28","author":"SS Hayreh","year":"2009","unstructured":"Hayreh, S. S. Ischemic optic neuropathy. Prog Retin Eye Res. 28, 34\u201362. https:\/\/doi.org\/10.1016\/j.preteyeres.2008.11.002 (2009).","journal-title":"Prog Retin Eye Res."},{"key":"99287_CR3","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/bjophthalmol-2019-314656","volume":"104","author":"SS Hayreh","year":"2020","unstructured":"Hayreh, S. S. Controversies on neuroprotection therapy in non-arteritic anterior ischaemic optic neuropathy. Br. J. Ophthalmol. 104, 153\u2013156. https:\/\/doi.org\/10.1136\/bjophthalmol-2019-314656 (2020).","journal-title":"Br. J. Ophthalmol."},{"key":"99287_CR4","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/sj.cdd.4401365","volume":"11","author":"S Tajiri","year":"2004","unstructured":"Tajiri, S. et al. Ischemia-induced neuronal cell death is mediated by the Endoplasmic reticulum stress pathway involving CHOP. Cell. Death Differ. 11, 403\u2013415. https:\/\/doi.org\/10.1038\/sj.cdd.4401365 (2004).","journal-title":"Cell. Death Differ."},{"key":"99287_CR5","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.neulet.2014.05.042","volume":"575","author":"H Li","year":"2014","unstructured":"Li, H., Zhu, X., Fang, F., Jiang, D. & Tang, L. Down-regulation of GRP78 enhances apoptosis via CHOP pathway in retinal ischemia-reperfusion injury. Neurosci. Lett. 575, 68\u201373. https:\/\/doi.org\/10.1016\/j.neulet.2014.05.042 (2014).","journal-title":"Neurosci. Lett."},{"key":"99287_CR6","doi-asserted-by":"publisher","first-page":"743","DOI":"10.2147\/opth.s3009","volume":"2","author":"N Hata","year":"2008","unstructured":"Hata, N., Oshitari, T., Yokoyama, A., Mitamura, Y. & Yamamoto, S. Increased expression of IRE1alpha and stress-related signal transduction proteins in ischemia-reperfusion injured retina. Clin. Ophthalmol. 2, 743\u2013752. https:\/\/doi.org\/10.2147\/opth.s3009 (2008).","journal-title":"Clin. Ophthalmol."},{"key":"99287_CR7","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.brainres.2009.10.025","volume":"1308","author":"SH Doh","year":"2010","unstructured":"Doh, S. H., Kim, J. H., Lee, K. M., Park, H. Y. & Park, C. K. Retinal ganglion cell death induced by Endoplasmic reticulum stress in a chronic glaucoma model. Brain Res. 1308, 158\u2013166. https:\/\/doi.org\/10.1016\/j.brainres.2009.10.025 (2010).","journal-title":"Brain Res."},{"key":"99287_CR8","doi-asserted-by":"publisher","first-page":"5970","DOI":"10.1038\/srep05970","volume":"4","author":"HO Ikeda","year":"2014","unstructured":"Ikeda, H. O. et al. Novel VCP modulators mitigate major pathologies of rd10, a mouse model of retinitis pigmentosa. Sci. Rep. 4, 5970. https:\/\/doi.org\/10.1038\/srep05970 (2014).","journal-title":"Sci. Rep."},{"key":"99287_CR9","doi-asserted-by":"publisher","first-page":"31184","DOI":"10.1038\/srep31184","volume":"6","author":"T Hasegawa","year":"2016","unstructured":"Hasegawa, T. et al. Neuroprotective efficacies by KUS121, a VCP modulator, on animal models of retinal degeneration. Sci. Rep. 6, 31184. https:\/\/doi.org\/10.1038\/srep31184 (2016).","journal-title":"Sci. Rep."},{"key":"99287_CR10","doi-asserted-by":"publisher","first-page":"44873","DOI":"10.1038\/srep05970","volume":"7","author":"M Hata","year":"2017","unstructured":"Hata, M. et al. KUS121, a VCP modulator, attenuates ischemic retinal cell death via suppressing Endoplasmic reticulum stress. Sci. Rep. 7, 44873. https:\/\/doi.org\/10.1038\/srep05970 (2017).","journal-title":"Sci. Rep."},{"key":"99287_CR11","doi-asserted-by":"publisher","first-page":"e00624","DOI":"10.1016\/j.heliyon.2018.e00624","volume":"4","author":"Y Muraoka","year":"2018","unstructured":"Muraoka, Y. et al. KUS121, an ATP regulator, mitigates chorioretinal pathologies in animal models of age-related macular degeneration. Heliyon 4, e00624. https:\/\/doi.org\/10.1016\/j.heliyon.2018.e00624 (2018).","journal-title":"Heliyon"},{"key":"99287_CR12","doi-asserted-by":"publisher","first-page":"e0229068","DOI":"10.1371\/journal.pone.0229068","volume":"15","author":"HO Ikeda","year":"2020","unstructured":"Ikeda, H. O. et al. Safety and effectiveness of a novel neuroprotectant, KUS121, in patients with non-arteritic central retinal artery occlusion: an open-label, non-randomized, first-in-humans, phase 1\/2 trial. PLoS One. 15, e0229068. https:\/\/doi.org\/10.1371\/journal.pone.0229068 (2020).","journal-title":"PLoS One"},{"key":"99287_CR13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1001\/archfacial.2010.71","volume":"12","author":"CK Magill","year":"2010","unstructured":"Magill, C. K., Moore, A. M., Borschel, G. H. & Mackinnon, S. E. A new model for facial nerve research: the novel Transgenic Thy1-GFP rat. Arch. Facial Plast. Surg. 12, 315\u2013320. https:\/\/doi.org\/10.1001\/archfacial.2010.71 (2010).","journal-title":"Arch. Facial Plast. Surg."},{"key":"99287_CR14","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1167\/iovs.03-0274","volume":"44","author":"SL Bernstein","year":"2003","unstructured":"Bernstein, S. L., Guo, Y., Kelman, S. E., Flower, R. W. & Johnson, M. A. Functional and cellular responses in a novel rodent model of anterior ischemic optic neuropathy. Invest. Ophthalmol. Vis. Sci. 44, 4153\u20134162. https:\/\/doi.org\/10.1167\/iovs.03-0274 (2003).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"99287_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.exer.2013.11.012","volume":"118","author":"CH Chang","year":"2014","unstructured":"Chang, C. H., Huang, T. L., Huang, S. P. & Tsai, R. K. Neuroprotective effects of Recombinant human granulocyte colony-stimulating factor (G-CSF) in a rat model of anterior ischemic optic neuropathy (rAION). Exp. Eye Res. 118, 109\u2013116. https:\/\/doi.org\/10.1016\/j.exer.2013.11.012 (2014).","journal-title":"Exp. Eye Res."},{"key":"99287_CR16","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.exer.2006.10.002","volume":"84","author":"NO Danylkova","year":"2007","unstructured":"Danylkova, N. O., Alcala, S. R., Pomeranz, H. D. & McLoon, L. K. Neuroprotective effects of brimonidine treatment in a rodent model of ischemic optic neuropathy. Exp. Eye Res. 84, 293\u2013301. https:\/\/doi.org\/10.1016\/j.exer.2006.10.002 (2007).","journal-title":"Exp. Eye Res."},{"key":"99287_CR17","doi-asserted-by":"publisher","first-page":"20787","DOI":"10.1038\/s41598-020-77735-2","volume":"10","author":"M Saito","year":"2020","unstructured":"Saito, M. et al. A VCP modulator, KUS121, as a promising therapeutic agent for post-traumatic osteoarthritis. Sci. Rep. 10, 20787. https:\/\/doi.org\/10.1038\/s41598-020-77735-2 (2020).","journal-title":"Sci. Rep."},{"key":"99287_CR18","doi-asserted-by":"publisher","first-page":"15651","DOI":"10.1038\/s41598-021-95173-6","volume":"11","author":"S Iwai","year":"2021","unstructured":"Iwai, S. et al. KUS121 attenuates the progression of monosodium iodoacetate-induced osteoarthritis in rats. Sci. Rep. 11, 15651. https:\/\/doi.org\/10.1038\/s41598-021-95173-6 (2021).","journal-title":"Sci. Rep."},{"key":"99287_CR19","doi-asserted-by":"publisher","first-page":"F577","DOI":"10.1152\/ajprenal.00392.2021","volume":"322","author":"Y Hata","year":"2022","unstructured":"Hata, Y. et al. A novel VCP modulator KUS121 exerts renoprotective effects in ischemia-reperfusion injury with retaining ATP and restoring ERAD-processing capacity. Am. J. Physiol. Ren. Physiol. 322, F577\u2013F586. https:\/\/doi.org\/10.1152\/ajprenal.00392.2021 (2022).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"99287_CR20","doi-asserted-by":"publisher","first-page":"e0299882","DOI":"10.1371\/journal.pone.0299882","volume":"19","author":"K Yoshimoto","year":"2024","unstructured":"Yoshimoto, K. et al. KUS121, a VCP modulator, protects against ischemic injury in random pattern flaps. PLoS One. 19, e0299882. https:\/\/doi.org\/10.1371\/journal.pone.0299882 (2024).","journal-title":"PLoS One"},{"key":"99287_CR21","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3390\/cells13030202","volume":"13","author":"Y Guo","year":"2024","unstructured":"Guo, Y., Mehrabian, Z., Milbrandt, J., DiAntonio, A. & Bernstein, S. L. Synergistic protection of retinal ganglion cells (RGCs) by SARM1 inactivation with CNTF in a rodent model of nonarteritic anterior ischemic optic neuropathy. Cells 13, 202. https:\/\/doi.org\/10.3390\/cells13030202 (2024).","journal-title":"Cells"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99287-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99287-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99287-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T15:36:24Z","timestamp":1745768184000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99287-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,27]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["99287"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-99287-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,27]]},"assertion":[{"value":"30 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Kyoto University has applied for patents related to this study (PCT\/JP2011\/067320&PCT\/JP2011\/073160), with Hanako Ohashi Ikeda and Masayuki Hata listed as inventors. Chinami Kikkawa is an employee of Santen Pharmaceutical Co., Ltd. A part of this study was conducted as a collaborative research project between Kyoto University and Santen Pharmaceutical Co., Ltd. All other authors declare that no competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14721"}}